Sofinnova Investments, Inc. Crispr Therapeutics Ag Put Options Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2018 Nov 15, 2018	SELL	$44.35 - $65.71 $8.87 Million - $13.1 Million	-200,000 Closed	0 $0
Q2 2018 Nov 15, 2018	BUY	$42.62 - $73.59 $7.65 Million - $13.2 Million	179,400 Added 870.87%	200,000 $11.8 Million
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $877,972 - $1.52 Million	20,600 New	20,600 $1.21 Million

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.48B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.